{"podcast":{"title":"The Energy Code","slug":"the-energy-code-2136601","podcast_index_feed_id":2136601,"rss_url":"https://feed.podbean.com/theenergycode/feed.xml","website_url":"https://feed.podbean.com/theenergycode/feed.xml","image_url":"https://pbcdn1.podbean.com/imglogo/image-logo/10635338/Energy_Code_Apple_Podcast_Cover_Final.jpg","author":"Dr. Mike Belkowski","episode_count":369,"summary":"The Red Light Report podcast is your number one source for all things red light therapy, hosted by Dr. Mike Belkowski, the founder and CEO of BioLight. Dr. Belkowski discusses the many health-related benefits of properly utilizing red light therapy and explores the best and most recent research related to photobiomodulation (ie, red light therapy). He will also be interviewing some of the most interesting and respected health, wellness, longevity and biohacking experts from around the world. Want to learn even more about red light therapy? Check out these sources: www.biolight.shop – Instagram @biolight.shop – YouTube BioLight","last_synced_at":"2026-07-23T22:20:31.206492+00:00","page_url":"https://stenobird.com/podcast/the-energy-code-2136601"},"episode":{"title":"Liver Cancer’s Hidden Engine: How Tumors Hijack Mitochondria to Survive, Spread, and Resist Therapy","slug":"liver-cancer-s-hidden-engine-how-tumors-hijack-mitochondria-to-survive-spread-and-resist-therapy","published_at":"2026-04-14T14:52:07+00:00","page_url":"https://stenobird.com/podcast/the-energy-code-2136601/liver-cancer-s-hidden-engine-how-tumors-hijack-mitochondria-to-survive-spread-and-resist-therapy","show_page_url":"https://stenobird.com/podcast/the-energy-code-2136601","url":"https://theenergycode.podbean.com/e/liver-cancer-s-hidden-engine-how-tumors-hijack-mitochondria-to-survive-spread-and-resist-therapy/","audio_url":"https://mcdn.podbean.com/mf/web/apw8yptiv53cfaed/Liver_mixdown.mp3","summary":"Liver cancer is not merely uncontrolled growth, but a strategic hijacking of mitochondrial failure to fuel tumor survival. This deep dive explores how tumors repurpose oxidative stress, mitophagy, and calcium dysregulation into a robust architecture for resistance and invasion.","meta_description":"Explore how liver cancer cells exploit mitochondrial dysfunction, ROS imbalance, and the Warburg effect to drive tumor progression and drug resistance.","key_points":["Main idea: Liver cancer uses mitochondrial dysfunction as a survival architecture rather than just tolerating it","Failure mode: mtDNA damage creates a self-amplifying loop of electron transport chain instability and increased ROS","Practical takeaway: Mitophagy acts as a double-edged sword, suppressing tumor initiation early but supporting tumor persistence in established cancer","Main idea: The Warburg effect provides a strategic advantage by supporting rapid ATP production and anabolic building blocks","Therapeutic frontier: Future treatments must move beyond single drugs toward precision combinations that target specific metabolic subtypes"],"chapters":[{"start_ms":60000,"title":"The Mitochondrial Hijacking Thesis","summary":"An introduction to the concept that liver cancer is a disease of mitochondrial adaptation and repurposing."},{"start_ms":180000,"title":"Key Drivers of Dysfunction","summary":"An overview of the primary mitochondrial defects in HCC, including ROS accumulation and mtDNA mutations."},{"start_ms":360000,"title":"The Warburg Effect and Metabolic Shifts","summary":"How cancer cells compensate for inefficient oxidative phosphorylation by increasing dependence on glycolysis."},{"start_ms":540000,"title":"The Dual Role of Mitophagy","summary":"Analyzing how mitophagy transitions from a tumor-suppressive quality control mechanism to a pro-tumor survival tool."},{"start_ms":720000,"title":"Calcium Dysregulation and Apoptotic Resistance","summary":"How abnormal calcium handling and anti-apoptotic buffering allow cells to endure chronic stress without dying."},{"start_ms":900000,"title":"Therapeutic Strategies and Precision Medicine","summary":"Exploring interventions targeting the electron transport chain, mtDNA stability, and the necessity of biomarker-driven delivery."},{"start_ms":1080000,"title":"Challenges in Clinical Application","summary":"Addressing tumor heterogeneity and the risks of off-target effects in healthy metabolic tissues."}],"topics":["Hepatocellular Carcinoma","Mitochondrial Biology","Metabolic Reprogramming","Oxidative Stress","Warburg Effect","Mitophagy","Precision Oncology","ATP Production"],"duration_seconds":1327,"processing_state":"processed","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-energy-code-2136601/episodes/liver-cancer-s-hidden-engine-how-tumors-hijack-mitochondria-to-survive-spread-and-resist-therapy/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-energy-code-2136601/liver-cancer-s-hidden-engine-how-tumors-hijack-mitochondria-to-survive-spread-and-resist-therapy.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}